| Antibody-targeted liposomes in cancer therapy and imaging S Sofou, G Sgouros Expert opinion on drug delivery 5 (2), 189-204, 2008 | 204 | 2008 |
| Radionuclide carriers for targeting of cancer S Sofou International journal of nanomedicine 3 (2), 181-199, 2008 | 152 | 2008 |
| Engineered liposomes for potential α-particle therapy of metastatic cancer S Sofou, JL Thomas, H Lin, MR McDevitt, DA Scheinberg, G Sgouros Journal of Nuclear Medicine 45 (2), 253-260, 2004 | 142 | 2004 |
| Anti–prostate-specific membrane antigen liposomes loaded with 225Ac for potential targeted antivascular α-particle therapy of cancer A Bandekar, C Zhu, R Jindal, F Bruchertseifer, A Morgenstern, S Sofou Journal of Nuclear Medicine 55 (1), 107-114, 2014 | 123 | 2014 |
| Enhanced retention of the α-particle-emitting daughters of actinium-225 by liposome carriers S Sofou, BJ Kappel, JS Jaggi, MR McDevitt, DA Scheinberg, G Sgouros Bioconjugate chemistry 18 (6), 2061-2067, 2007 | 109 | 2007 |
| Enhanced Loading Efficiency and Retention of 225Ac in Rigid Liposomes for Potential Targeted Therapy of Micrometastases MY Chang, J Seideman, S Sofou Bioconjugate chemistry 19 (6), 1274-1282, 2008 | 88 | 2008 |
| Surface-active liposomes for targeted cancer therapy S Sofou Nanomedicine 2 (5), 711-724, 2007 | 85 | 2007 |
| Time-restricted feeding and the realignment of biological rhythms: translational opportunities and challenges J Sunderram, S Sofou, K Kamisoglu, V Karantza, IP Androulakis Journal of translational medicine 12, 1-9, 2014 | 76 | 2014 |
| Targeted and nontargeted α-particle therapies MR McDevitt, G Sgouros, S Sofou Annual review of biomedical engineering 20 (1), 73-93, 2018 | 72 | 2018 |
| The pH-dependent association with cancer cells of tunable functionalized lipid vesicles with encapsulated doxorubicin for high cell-kill selectivity S Karve, A Bandekar, MR Ali, S Sofou Biomaterials 31 (15), 4409-4416, 2010 | 58 | 2010 |
| Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin A Bandekar, S Karve, MY Chang, Q Mu, J Rotolo, S Sofou Biomaterials 33 (17), 4345-4352, 2012 | 55 | 2012 |
| Masking and Triggered Unmasking of Targeting Ligands on Liposomal Chemotherapy Selectively Suppress Tumor Growth in Vivo A Bandekar, C Zhu, A Gomez, MZ Menzenski, M Sempkowski, S Sofou Molecular Pharmaceutics 10 (1), 152-160, 2013 | 50 | 2013 |
| Heterogeneous Domains and Membrane Permeability in Phosphatidylcholine− Phosphatidic Acid Rigid Vesicles As a Function of pH and Lipid Chain Mismatch S Karve, G Bajagur Kempegowda, S Sofou Langmuir 24 (11), 5679-5688, 2008 | 49 | 2008 |
| Stable adhesion of phospholipid vesicles to modified gold surfaces S Sofou, JL Thomas Biosensors and Bioelectronics 18 (4), 445-455, 2003 | 49 | 2003 |
| The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy S Karve, A Alaouie, Y Zhou, J Rotolo, S Sofou Biomaterials 30 (30), 6055-6064, 2009 | 47 | 2009 |
| Alpha-particle radiotherapy: For large solid tumors diffusion trumps targeting C Zhu, M Sempkowski, T Holleran, T Linz, T Bertalan, A Josefsson, ... Biomaterials 130, 67-75, 2017 | 46 | 2017 |
| Liposomes with triggered content release for cancer therapy AM Alaouie, S Sofou Journal of Biomedical Nanotechnology 4 (3), 234-244, 2008 | 44 | 2008 |
| Floret-shaped solid domains on giant fluid lipid vesicles induced by pH A Bandekar, S Sofou Langmuir 28 (9), 4113-4122, 2012 | 43 | 2012 |
| Kinetic analysis of nanostructures formed by enzyme-instructed intracellular assemblies against cancer cells J Li, D Bullara, X Du, H He, S Sofou, IG Kevrekidis, IR Epstein, B Xu ACS nano 12 (4), 3804-3815, 2018 | 39 | 2018 |
| Heterogeneous Liposome Membranes with pH-Triggered Permeability Enhance the in Vitro Antitumor Activity of Folate-Receptor Targeted Liposomal Doxorubicin E Mamasheva, C O’Donnell, A Bandekar, S Sofou Molecular pharmaceutics 8 (6), 2224-2232, 2011 | 36 | 2011 |
